# ADCETRIS

NDC: 51144-050
Generic name: brentuximab vedotin
Labeler / Manufacturer: SEAGEN INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20110825

FDA application: BLA125388

## Active ingredients

- BRENTUXIMAB VEDOTIN: 50 mg/10.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51144-050"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51144-050
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f